Sanai Health Industry Group (SEHK:1889) - Share price, News & Analysis

1889 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	4/6
Financial Health	6/6
Dividends	0/6

1889 Stock Overview

Sanai Health Industry Group Company Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People’s Republic of China.

Rewards

Earnings grew by 40.5% over the past year

Risk Analysis

Highly volatile share price over the past 3 months

Does not have a meaningful market cap (HK$267M)

Sanai Health Industry Group Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sanai Health Industry Group
Historical stock prices
Current Share Price	HK$0.087
52 Week High	HK$0.28
52 Week Low	HK$0.042
Beta	1.35
1 Month Change	7.41%
3 Month Change	61.11%
1 Year Change	n/a
3 Year Change	-51.93%
5 Year Change	-77.69%
Change since IPO	-95.56%

Recent News & Updates

May 15

What Sanai Health Industry Group Company Limited's (HKG:1889) 35% Share Price Gain Is Not Telling You

Those holding Sanai Health Industry Group Company Limited ( HKG:1889 ) shares would be relieved that the share price...

Shareholder Returns

	1889	HK Pharmaceuticals	HK Market
7D	14.5%	5.1%	-1.2%
1Y	n/a	-45.3%	-23.8%

Return vs Industry: Insufficient data to determine how 1889 performed against the Hong Kong Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how 1889 performed against the Hong Kong Market.

Price Volatility

Is 1889's price volatile compared to industry and market?
1889 volatility
1889 Average Weekly Movement	27.2%
Pharmaceuticals Industry Average Movement	6.2%
Market Average Movement	7.0%
10% most volatile stocks in HK Market	13.6%
10% least volatile stocks in HK Market	3.3%

Stable Share Price: 1889 is more volatile than 90% of Hong Kong stocks over the past 3 months, typically moving +/- 27% a week.

Volatility Over Time: 1889's weekly volatility has increased from 19% to 27% over the past year.

About the Company

Founded	Employees	CEO	Website
2006	81	n/a	https://www.1889hk.com

Sanai Health Industry Group Company Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People’s Republic of China. It operates through three segments: Pharmaceutical Products, Finance Leasing, and Genetic Testing and Molecular Diagnostic Services. The company provides branded prescription and non-prescription drugs, as well as Chinese pharmaceutical products.

Sanai Health Industry Group Fundamentals Summary

How do Sanai Health Industry Group's earnings and revenue compare to its market cap?
1889 fundamental statistics
Market Cap	CN¥227.78m
Earnings (TTM)	CN¥9.03m
Revenue (TTM)	CN¥67.61m

25.3x

P/E Ratio

3.4x

P/S Ratio

Is 1889 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
1889 income statement (TTM)
Revenue	CN¥67.61m
Cost of Revenue	CN¥27.16m
Gross Profit	CN¥40.45m
Other Expenses	CN¥31.42m
Earnings	CN¥9.03m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)	0.0029
Gross Margin	59.82%
Net Profit Margin	13.35%
Debt/Equity Ratio	0.0%

How did 1889 perform over the long term?

See historical performance and comparison

We’ve recently updated our valuation analysis.

Valuation

Is 1889 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 1889?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for 1889. This is calculated by dividing 1889's market cap by their current preferred multiple.
What is 1889's n/a Ratio?
n/a Ratio	0x
n/a	n/a
Market Cap	CN¥227.78m

1889 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	3.4x
Enterprise Value/EBITDA	8.2x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does 1889's PE Ratio compare to its peers?

1889 PE Ratio vs Peers

The above table shows the PE ratio for 1889 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	PE	Estimated Growth	Market Cap
Peer Average	6.9x

Forward PE

Price-To-Earnings vs Peers: 1889 is expensive based on its Price-To-Earnings Ratio (25.3x) compared to the peer average (6.9x).

Price to Earnings Ratio vs Industry

How does 1889's PE Ratio compare vs other companies in the Hong Kong Pharmaceuticals Industry?

Price-To-Earnings vs Industry: 1889 is expensive based on its Price-To-Earnings Ratio (25.3x) compared to the Hong Kong Pharmaceuticals industry average (9.4x)

Price to Earnings Ratio vs Fair Ratio

What is 1889's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

1889 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	25.3x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 1889's Price-To-Earnings Fair Ratio for valuation analysis.

Share Price vs Fair Value

What is the Fair Price of 1889 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 1889's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 1889's fair value for valuation analysis.

Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 1889's PEG Ratio to determine if it is good value.

Discover undervalued companies

Future Growth

How is Sanai Health Industry Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE

5.1%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Sanai Health Industry Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Discover growth companies

Check out Sanai Health Industry Group's track record over time to understand how much the company has returned to shareholders and its earnings growth rate in the past.
Sanai Health Industry Group competitive advantages and company strategy can generally be found in its financial reports archived here.

Past Performance

How has Sanai Health Industry Group performed over the past 5 years?

Past Performance Score

4/6

Past Performance Score 4/6

Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE

66.1%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 1889 has high quality earnings.

Growing Profit Margin: 1889's current net profit margins (13.3%) are higher than last year (5.3%).

Past Earnings Growth Analysis

Earnings Trend: 1889 has become profitable over the past 5 years, growing earnings by 66.1% per year.

Accelerating Growth: 1889's earnings growth over the past year (40.5%) is below its 5-year average (66.1% per year).

Earnings vs Industry: 1889 earnings growth over the past year (40.5%) exceeded the Pharmaceuticals industry 16.1%.

Return on Equity

High ROE: 1889's Return on Equity (7.7%) is considered low.

Discover strong past performing companies

Financial Health

How is Sanai Health Industry Group's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage

Financial Position Analysis

Short Term Liabilities: 1889's short term assets (CN¥188.9M) exceed its short term liabilities (CN¥90.1M).

Long Term Liabilities: 1889's short term assets (CN¥188.9M) exceed its long term liabilities (CN¥1.6M).

Debt to Equity History and Analysis

Debt Level: 1889 is debt free.

Reducing Debt: 1889 has no debt compared to 5 years ago when its debt to equity ratio was 7.1%.

Debt Coverage: 1889 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 1889 has no debt, therefore coverage of interest payments is not a concern.

Balance Sheet

Discover healthy companies

Dividend

What is Sanai Health Industry Group current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate 1889's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate 1889's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 1889's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 1889's dividend payments have been increasing.

Earnings Payout to Shareholders

Earnings Coverage: 1889 is not paying a notable dividend for the Hong Kong market.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as 1889 has not reported any payouts.

Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

2.9yrs

Average management tenure

CEO

Sanai Health Industry Group has no CEO, or we have no data on them.

Leadership Team

Experienced Management: 1889's management team is considered experienced (2.9 years average tenure).

Board Members

Experienced Board: 1889's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.

Ownership

Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Data	Last Updated (UTC time)
Company Analysis	2022/06/23 00:00
End of Day Share Price	2022/06/23 00:00
Earnings	2021/12/31
Annual Earnings	2021/12/31